Skip to content
Research Article Open access CC BY 4.0

A Review of the Innate Immune Evasion Mechanisms and Status of Vaccine Development of Klebsiella pneumonia

Fredrick Ruo Tiria, Lillian Musila

Microbiology Research Journal International · pp. 33–47 · Published 20 Mar 2021

10.9734/mrji/2021/v31i130290

Abstract

Klebsiella pneumoniae (KP) is a human pathogen causing a broad spectrum of diseases such as urinary tract infections (UTI), pneumonia, pyogenic liver abscess, bloodstream infections, and sepsis. Neonate, geriatric and immunocompromised individuals are the most vulnerable to KP infections. The success of KP as an infectious agent is due to the evolution of various mechanisms to evade the host's immune system. These diverse mechanisms have led to the dominance of KP infections in community settings where hypervirulent strains predominate and in hospital-acquired infections where multidrug-resistant strains predominate. KP infections in the past decades have been increasingly associated with high morbidity and mortality due to the emergence of multidrug-resistant and hypervirulent strains capable of evading both the internal immune defense mechanisms and external antimicrobial agents. The pharmaceutical industries have very few and often expensive new antibiotics in the pipeline, offering little hope for antibiotic therapy. The development of new therapeutic strategies such as polyvalent, biconjugate vaccines that can provide protective immunity, especially against vulnerable populations, can mitigate the effects of KP infections. In this review, we discuss the virulence mechanisms of KP and how it evades the innate host immunity, and the interplay between the virulence and immune evasion strategies. The progress in the search for a vaccine to protect against KP infections will also be highlighted.

Klebsiella pneumoniae antimicrobial peptides biofilm hypervirulence innate immunity complement system biconjugate vaccines

References (54)

  1. 1 Klebsiella spp. as Nosocomial Pathogens: Epidemiology, Taxonomy, Typing Methods, and Pathogenicity Factors [DOI]
  2. 2 Klebsiella pneumoniae: Going on the Offense with a Strong Defense [DOI]
  3. 3 The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria [DOI]
  4. 4 Hypervirulent (hypermucoviscous) Klebsiella pneumoniae [DOI]
  5. 5 Colonization, Infection, and the Accessory Genome of Klebsiella pneumoniae [DOI]
  6. 6 The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide Vaccine [DOI]
  7. 7 Klebsiella pneumoniae liver abscess: a new invasive syndrome [DOI]
  8. 8 Resistance in Gram-Negative Bacteria: Enterobacteriaceae [DOI]
  9. 9 Hospital-acquired neonatal infections in developing countries [DOI]
  10. 10 Gastrointestinal Carriage Is a Major Reservoir of Klebsiella pneumoniae Infection in Intensive Care Patients [DOI]
  11. 11 Klebsiella pneumoniae infection biology: living to counteract host defences [DOI]
  12. 12 Association between rmpA and magA Genes and Clinical Syndromes Caused by Klebsiella pneumoniae in Taiwan [DOI]
  13. 13 Molecular Pathogenesis of Klebsiella Pneumoniae [DOI]
  14. 14 Relationship Between Biofilm Formation and Antimicrobial Resistance in Gram-Negative Bacteria [DOI]
  15. 15 Antibiotic Resistance Related to Biofilm Formation in Klebsiella pneumoniae [DOI]
  16. 16 Role of type 1 and type 3 fimbriae in Klebsiella pneumoniae biofilm formation [DOI]
  17. 17 Emergence of Klebsiella pneumoniae Carbapenemase-Producing Bacteria [DOI]
  18. 18 Biofilm formation and antibiotic resistance in Klebsiella pneumoniae urinary strains [DOI]
  19. 19 RmpA Regulation of Capsular Polysaccharide Biosynthesis in Klebsiella pneumoniae CG43 [DOI]
  20. 20 Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review [DOI]
  21. 21 The role of Klebsiella pneumoniae rmpA in capsular polysaccharide synthesis and virulence revisited [DOI]
  22. 22 Epidemiology and Virulence of Klebsiella pneumoniae [DOI]
  23. 23 Colistin resistance in Klebsiella pneumoniae [DOI]
  24. 24 A promising bioconjugate vaccine against hypervirulent Klebsiella pneumoniae [DOI]
  25. 25 Capsule and Fimbria Interaction in Klebsiella pneumoniae [DOI]
  26. 26 The Serum Resistome of a Globally Disseminated Multidrug Resistant Uropathogenic Escherichia coli Clone [DOI]
  27. 27 A Klebsiella pneumoniae antibiotic resistance mechanism that subdues host defences and promotes virulence [DOI]
  28. 28 Klebsiella pneumoniae: Virulence, Biofilm and Antimicrobial Resistance [DOI]
  29. 29 Polysaccharide capsule-mediated resistance to opsonophagocytosis in Klebsiella pneumoniae [DOI]
  30. 30 Distinct localization of the complement C5b-9 complex on Gram-positive bacteria [DOI]
  31. 31 Analysis of the Complement System in the Clinical Immunology Laboratory [DOI]
  32. 32 Clinical and Genomic Analysis of Liver Abscess-Causing Klebsiella pneumoniae Identifies New Liver Abscess-Associated Virulence Genes [DOI]
  33. 33 Bacterial killing by complement requires membrane attack complex formation via surface‐bound C5 convertases [DOI]
  34. 34 Deciphering the role of the capsule of Klebsiella pneumoniae during pathogenesis: A cautionary tale [DOI]
  35. 35 Role of capsule and O antigen in resistance of Klebsiella pneumoniae to serum bactericidal activity [DOI]
  36. 36 Quorum sensing affects biofilm formation through lipopolysaccharide synthesis in Klebsiella pneumoniae [DOI]
  37. 37 Development of immunization trials against Klebsiella pneumoniae [DOI]
  38. 38 Association of Antibiotic Resistance, Cell Adherence, and Biofilm Production with the Endemicity of Nosocomial Klebsiella pneumoniae [DOI]
  39. 39 Hypermucoviscous Klebsiella pneumoniae: A challenge in community acquired infection [DOI]
  40. 40 Identification and characterization of antigens as vaccine candidates againstKlebsiella pneumoniae [DOI]
  41. 41 Complement mediated Klebsiella pneumoniae capsule changes [DOI]
  42. 42 Synthetic Immunotherapeutics against Gram-negative Pathogens [DOI]
  43. 43 Novel assays to assess the functional capacity of the classical, the alternative and the lectin pathways of the complement system [DOI]
  44. 44 Phylogenetic Analysis of Multi-Drug Resistant Klebsiella pneumoniae Strains From Duodenoscope Biofilm: Microbiological Surveillance and Reprocessing Improvements for Infection Prevention [DOI]
  45. 45 Targeting subcapsular antigens for prevention of Klebsiella pneumoniae infections [DOI]
  46. 46 Emergence of hypervirulent K. pneumoniae causing complicated UTI in kidney stone patients [DOI]
  47. 47 Role of lipopolysaccharide and complement in susceptibility of Klebsiella pneumoniae to nonimmune serum [DOI]
  48. 48 Dynamics of Human Complement–Mediated Killing of Klebsiella pneumoniae [DOI]
  49. 49 An Antibody-Complement System in Human Serum Lethal to L-Phase Variants of Bacteria [DOI]
  50. 50 Can the rmpA gene predict metastatic meningitis among patients with primary Klebsiella pneumoniae liver abscess? [DOI]
  51. 51 Resistance in gram-negative bacteria: Enterobacteriaceae [DOI]
  52. 52 Human polymicrobial infections [DOI]
  53. 53 Genomic Profiling Reveals Distinct Routes To Complement Resistance in Klebsiella pneumoniae [DOI]
  54. 54 Progress in pathogenic mechanism of hypervirulent Klebsiella pneumoniae [DOI]

Cited by 6

Variable progressive behavior of Klebsiella pneumoniae at different sites of infection

Tarek Adnan Ahmad, Dina M. Tawfik, Hossam Ghoneim · Frontiers in Immunology · 2026

Showing 5 of 6 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

45

Page views

0

PDF downloads

5

Outbound clicks

6

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.